Phase II Study of Single Agent OSI-7904L in Patients With Gastric or Gastroesophageal (GEJ) Cancer
NCT00073502
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
43
Enrollment
INDUSTRY
Sponsor class
Conditions
Gastroesophageal Adenocarcinoma
Gastric Adenocarcinoma
Interventions
DRUG:
OSI-7904L
Sponsor
OSI Pharmaceuticals